874347-50-9

Upstream product

• 23602-64-4 2-hydroxy-3-iodo-benzaldehyde 
• 874347-49-6 3-iodo-2-methoxy-benzaldehyde 

Downstream Products

• 1009091-77-3 C₁₁H₁₂INO₄ 
• 943238-72-0 C₁₆H₂₀INO₇S 
• 1009094-21-6 C₅₃H₈₂N₆O₉SSi 
• 1009094-19-2 C₅₂H₇₉N₅O₇Si 
• 1009094-20-5 C₄₇H₆₈N₆O₉S 
• 1009093-41-7 C₅₂H₆₇N₅O₆ 
• 1009093-13-3 C₄₇H₆₅N₅O₇ 
• 1009092-96-9 C₄₆H₆₆N₆O₈S 
• 1009094-40-9 C₄₆H₆₄N₆O₇ 
• 1009094-39-6 C₄₇H₆₆N₆O₇ 
• 1009093-74-6 C₄₇H₆₅N₅O₇ 
• 1009094-38-5 C₄₈H₆₈N₆O₇ 
• 1009094-36-3 C₄₆H₆₃N₅O₈ 
• 1009094-15-8 C₄₆H₆₅N₅O₇ 

Relevant academic research and scientific papers

Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners

The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.